To view a copy of this licence, visit About this article Cite this article Dong, S., Li, T
Sensitivity analysis To ensure that any short-term outcomes in the GLP-1 agonists or control groups were not due to chronic high-risk factors not accounted for in PSM, we performed a sensitivity analysis by performing the same analysis listed above and excluding outcomes within 1 year after the index event
Eur J Clin Pharmacol 79(9):123948 Mailhac A, Pedersen L, Pottegrd A, Sndergaard J, Mogensen T, Srensen HT et al (2024) Semaglutide (Ozempic) Use in Denmark 2018 through 2023 - user trends and off-label prescribing for weight loss
Dosing is individualized based on body weight, age, and clinical response, with typical starting doses of 1.6 mcg/kg/day in younger adults
It affects roughly 1 in 50 people at some point